Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PEComas”

68 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 68 results

Not applicableUnknownNCT04577937
What this trial is testing

Sleep Patterns in Patients Affected by Lymphangioleiomiomatosis

Who this might be right for
LymphangioleiomyomatosisSleep DisorderSleep Apnea Syndromes+1 more
dr. Stefano Nava 15
Testing effectiveness (Phase 2)Study completedNCT01353209
What this trial is testing

Letrozole for Lymphangioleiomyomatosis

Who this might be right for
Lymphangioleiomyomatosis
University of Cincinnati 17
Not applicableApproved For MarketingNCT03817515
What this trial is testing

Expanded Access for ABI-009 in Patients With Advanced PEComa and Patients With a Malignancy With Relevant Genetic Mutations or mTOR Pathway Activation

Who this might be right for
PEComa, MalignantTSC1TSC2+1 more
Aadi Bioscience, Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 818
Post-approval studies (Phase 4)Study completedNCT03525834
What this trial is testing

Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.

Who this might be right for
Renal Angiomyolipoma
Novartis Pharmaceuticals 40
Post-approval studies (Phase 4)Active Not RecruitingNCT05252585
What this trial is testing

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

Who this might be right for
Renal Angiomyolipoma
Novartis Pharmaceuticals 4
Not applicableActive Not RecruitingNCT06453642
What this trial is testing

Evaluation of a Simple-Prep Controlled Embolic

Who this might be right for
EmbolizationVascular TumorRenal Angiomyolipoma+3 more
Fluidx Medical Technology, Inc. 114
Post-approval studies (Phase 4)Study completedNCT01217125
What this trial is testing

Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis

Who this might be right for
Angiomyolipoma
Fundacio Puigvert 18
Early research (Phase 1)Study completedNCT04388371
What this trial is testing

Glutamine PET Imaging in LAM

Who this might be right for
Lymphangioleiomyomatosis (LAM)
Vanderbilt University Medical Center 5
Not applicableUnknownNCT05617105
What this trial is testing

Molecular Characterization of Perivascular Epithelioid Cell Tumors

Who this might be right for
Perivascular Epithelioid Cell Tumor, Malignant
University Hospital, Strasbourg, France 100
Not applicableEnrolling By InvitationNCT05727852
What this trial is testing

Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases

Who this might be right for
Chronic Respiratory DiseasesCystic FibrosisLymphangioleiomyomatosis+4 more
I.M. Sechenov First Moscow State Medical University 400
Very early researchUnknownNCT05087134
What this trial is testing

Characterizing LAM With 11C-Choline PET/CT

Who this might be right for
Lymphangioleiomyomatosis
Peking Union Medical College Hospital 50
Not applicableLooking for participantsNCT06405997
What this trial is testing

The Genotype and Phenotype of Lymphangioleiomyomatosis

Who this might be right for
Sporadic LymphangioleiomyomatosisTSC-associated Lymphangioleiomyomatosis
National Taiwan University Hospital 100
Testing effectiveness (Phase 2)Study completedNCT03190174
What this trial is testing

Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers

Who this might be right for
Ewing SarcomaPEComaEpithelioid Sarcoma+11 more
Sarcoma Oncology Research Center, LLC 34
Not applicableStudy completedNCT00005486
What this trial is testing

Lymphangioleiomyomatosis (LAM) Registry

Who this might be right for
Lung DiseasesLymphangiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableStudy completedNCT00001869
What this trial is testing

Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM)

Who this might be right for
Leiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI) 400
Testing effectiveness (Phase 2)Study completedNCT03062943
What this trial is testing

Nintedanib for LymphAngioleioMyomatosis (LAM)

Who this might be right for
Lymphangioleiomyomatosis
IRCCS Multimedica 30
Large-scale testing (Phase 3)Active Not RecruitingNCT03150914
What this trial is testing

Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial

Who this might be right for
LAMLymphangioleiomyomatosis
University of Cincinnati 60
Testing effectiveness (Phase 2)Study completedNCT00005906
What this trial is testing

Treatment With Octreotide in Patients With Lymphangioleiomyomatosis

Who this might be right for
LymphangioleiomyomatosisLymphangiomyomasPleural Effusions+1 more
National Heart, Lung, and Blood Institute (NHLBI) 4
Early research (Phase 1)Study completedNCT01687179
What this trial is testing

Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis

Who this might be right for
Lymphangioleiomyomatosis
Brigham and Women's Hospital 14
Load More Results